The race to uncover the following 10-baggers is on now that markets appear to be nicely alongside within the strategy of signaling to buyers that the brand new bull has been born.
Proof is throughout: investor sentiment has rebounded from deep pessimism to sudden optimism on shares. A Reuters ballot this week of analysts finds that each one 106 anticipate the Fed to hike by 25bps at subsequent week’s assembly, taking the Fed Funds benchmark in a single day rate of interest to the 5.25%-5.50% vary. However solely 19 of them suppose the Fed will hike any extra after that. And but, there are not any indicators—even on the distant horizon—of recession danger.
In the meantime, new bull market themes are arising, and a brand new paradigm of development is rising. With a lot money on the sidelines, the stage is ready for some probably rewarding motion for small-cap development buyers in a position to spot new darlings within the making.
One such potential “darling within the making” on the Nasdaq remains to be buying and selling below $2/share however with rising gross sales and a rising model footprint in an explosive development market: Mangoceuticals, Inc. (NASDAQ: MGRX).
We’ve profiled the identify earlier than. However information this week suggests the potential for a sooner path towards blossoming into excessive visibility as a development play than we had been anticipating.
Disrupting a $31 Billion Market
MGRX administration has began to reveal a novel ability for advertising and marketing and messaging. The corporate operates within the the boys’s well being and wellness house, which is price over $30 billion worldwide and is rising at a staggering compound annual development charge (CAGR) of 15.00% by 2029, signaling substantial potential for buyers.
In that house, there hasn’t been a complete lot of spectacular work achieved on the advertising and marketing facet. MGRX goals to alter that.
This issue has two faces.
First, the corporate has achieved a terrific job of discovering a probably disruptive messaging tone. Its flagship product is Mango, and ED therapy that mixes a number of compounds to focus on the challenges males face in intimate conditions, crafted with FDA-approved components. It now has each tadalafil and sildenafil variations.
The messaging round these merchandise is designed to leverage humor and an open and assured framing of the pursuit of male well being and private enchancment to defuse social taboos and normalize ED as a generally shared practical situation that may be solved.
In different phrases, the entire stigma round ED is the most important hurdle ED manufacturers face in advertising and marketing and promoting merchandise. MGRX might be the one participant on the sector immediately confronting that truth and navigating round it to the endzone.
The second level is the highly effective alignment the corporate is constructing within the media channels it chooses to take advantage of from a advertising and marketing standpoint: podcasts which have big engagement, recognition, and development within the younger male demo.
That’s hardly the one avenue the corporate is concentrating on, however that facet may show to be an infinite benefit when taken in tandem with its disruptive messaging strategy. Make it humorous. Make it regular. Make it no huge deal. And get in entrance of males watching media efficiently concentrating on the male demo.
After partnering with Gronk’s Ice Shaker model, MGRX turned a featured sponsor on Barstool Sports activities and the Solely Stans podcast sensation.
The corporate has additionally launched its “Make America Exhausting Once more” marketing campaign, which might be augmented by a devoted net presence and a promise to the marketing campaign into its different advertising and marketing efforts to drive a nationwide motion for males’s well being and wellness that feeds again into consciousness across the firm’s merchandise.
No Jumper
Now, simply this week, MGRX introduced it has been engaged as an unique new sponsor by Adam22 and might be featured on a collection of No Jumper and Plug Speak episodes starting in August 2023 (https://www.youtube.com/@NoJumper).
“Adam22 has his finger on the heartbeat of a demographic that represents a wonderful match for MangoRx, offering a brand new highway to reaching our income development targets by reaching massive audiences and selling our merchandise nationwide,” said MGRX Co-Founder and CEO, Jacob Cohen. “Our focus proper now could be on driving highly effective gross sales development. This partnership holds the potential to create an infinite bump in model consciousness, gross sales, and market share within the rising males’s well being and wellness market, and we sit up for working with Adam and his crew starting subsequent month.”
In line with the corporate’s launch, each the No Jumper and Plug Speak podcasts have grown to amass massive, engaged audiences. The No Jumper social media universe has amassed practically 12 million followers throughout YouTube, Instagram, Tik Tok, Twitter, and Snapchat. Almost 90% of these followers are male, and 93% are between 18-44 years of age, suggesting a really robust correlation between the MangoRx goal market and the massive and rising No Jumper viewers.
Reportedly, every No Jumper podcast episode averages 100-150k views/downloads, with the No Jumper channel receiving roughly 20 million month-to-month views. Plug Speak is new, however rising extraordinarily quick, with 30 thousand new subscribers per thirty days and over 50 thousand views per episode.
“We welcome MangoRx on board with open arms,” said Josh Manheim, Chief Working Officer of No Jumper. “We sit up for working with Jacob and his crew, and we actually consider it is a scenario the place everybody’s pursuits are very nicely aligned towards a mutually useful final result. MangoRx is a disruptive new face in its market, and they’re as soon as once more proving that id with this partnership.”
Cohen continued, “Previous No Jumper episodes have reached into the tens of tens of millions of views, reaching an enormous viewers that’s extraordinarily well-aligned with our goal market demographic. The present’s most up-to-date episode hit 10 thousand views inside two hours of being posted. It is a cultural phenomenon with monumental traction. Our promotional spots ought to be extremely impactful, with a minimum of a full minute of natural airtime dedicated to MangoRx and our merchandise and imaginative and prescient. We couldn’t be extra excited in regards to the alternative this represents.”
All of this follows the corporate’s latest profitable IPO on the Nasdaq, which generated $5,000,000 in gross proceeds earmarked to fund product consciousness and operational enlargement as the corporate launches its flagship product line.
For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com
